Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Spain

Hospital Mutua de Terrassa, Terrassa

Phase

Safety & dosing

Sponsor

Hospital Mutua de Terrassa

Collaborators

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Germans Trias i Pujol Hospital

Enrollment target

~90 participants

Started

July 2024

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 100 Years

Sex

Female only

Last updated January 2025